OMICS ANALYSIS OF THE ANTI-GLIOMA EFFECT BY COMBINATION THERAPY OF VASCULOSTATIN EXPRESSING ONCOLYTIC VIRUS AND CILENGITIDE

被引：0
|
作者：
Fujii, Kentaro [1 ]
Kurozumi, Kazuhiko [1 ]
Ichikawa, Tomotsugu [1 ]
Onishi, Manabu [1 ]
Ishida, Joji [1 ]
Shimazu, Yosuke [1 ]
Kaur, Balveen [2 ]
Chiocca, E. Antonio [3 ,4 ]
Date, Isao [1 ]
机构：
[1] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan
[2] Ohio State Univ, Dept Neurol Surg, Dardinger Lab Neurooncol & Neurosci, Columbus, OH 43210 USA
[3] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[4] Faulkner Hosp, Dept Neurosurg, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus
    Fujii, K.
    Kurozumi, K.
    Ichikawa, T.
    Onishi, M.
    Shimazu, Y.
    Ishida, J.
    Chiocca, E. A.
    Kaur, B.
    Date, I.
    [J]. CANCER GENE THERAPY, 2013, 20 (08) : 437 - 444
  • [2] The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus
    K Fujii
    K Kurozumi
    T Ichikawa
    M Onishi
    Y Shimazu
    J Ishida
    E A Chiocca
    B Kaur
    I Date
    [J]. Cancer Gene Therapy, 2013, 20 : 437 - 444
  • [3] OMICS ANALYSIS OF THE ANTI-GLIOMA EFFECT OF CILENGITIDE
    Shimazu, Y.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 18 - 19
  • [4] THE INTEGRIN ANTAGONIST CILENGITIDE AUGUMENTS ANTI-TUMOR EFFECT OF VASCULOSTATIN-EXPRESSING ONCOLYTIC VIRUS
    Fujii, Kentaro
    Kurozumi, Kazuhiko
    Ichikawa, Tomotsugu
    Onishi, Manabu
    Shimazu, Yosuke
    Ishida, Joji
    Chiocca, E. Antonio
    Kaur, Balveen
    Date, Isao
    [J]. NEURO-ONCOLOGY, 2012, 14 : 28 - 28
  • [5] THE INTEGRIN ANTAGONIST CILENGITIDE ENHANCES ANTI-TUMOR EFFECT OF VASCULOSTATIN-EXPRESSING ONCOLYTIC VIRUS
    Fujii, K.
    Kurozumi, K.
    Ichikawa, T.
    Onishi, M.
    Shimazu, Y.
    Ishida, J.
    Chiocca, E.
    Kaur, B.
    Date, I.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 26 - 27
  • [6] THE INTEGRIN ANTAGONIST CILENGITIDE AUGUMENTS ANTITUMOR EFFICACY OF VASCULOSTATIN-EXPRESSING ONCOLYTIC VIRAL THERAPY
    Fujii, Kentaro
    Kurozumi, Kazuhiko
    Ichikawa, Tomotsugu
    Yoshida, Koichi
    Onishi, Manabu
    Michiue, Hiroyuki
    Chiocca, E. Antonio
    Kaur, Balveen
    Date, Isao
    [J]. JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 264 - 264
  • [7] Gene expression profiling of the anti-glioma effect of Cilengitide
    Onishi, Manabu
    Kurozumi, Kazuhiko
    Ichikawa, Tomotsugu
    Michiue, Hiroyuki
    Fujii, Kentaro
    Ishida, Joji
    Shimazu, Yosuke
    Chiocca, E. Antonio
    Kaur, Balveen
    Date, Isao
    [J]. SPRINGERPLUS, 2013, 2
  • [8] GENE EXPRESSION PROFILING OF THE ANTI-GLIOMA EFFECT OF CILENGITIDE
    Kurozumi, Kazuhiko
    Onishi, Manabu
    Ichikawa, Tomotsugu
    Fujii, Kentaro
    Ishida, Joji
    Shimazu, Yosuke
    Chiocca, E. Antonio
    Kaur, Balveen
    Date, Isao
    [J]. NEURO-ONCOLOGY, 2013, 15 : 4 - 5
  • [9] ONCOLYTIC VIRUS THERAPY OF GLIOMA SENSITIZES GLIOMA CELLS TO CILENGITIDE TREATMENT
    Kurozumi, Kazuhiko
    Haseley, Amy
    Alvarez-Breckenridge, Christopher
    Ichikawa, Tomotsugu
    Date, Isao
    Chiocca, E. Antonio
    Kaur, Balveen
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 883 - 883
  • [10] Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo
    M M Alonso
    C Gomez-Manzano
    H Jiang
    N B Bekele
    Y Piao
    W K A Yung
    R Alemany
    J Fueyo
    [J]. Cancer Gene Therapy, 2007, 14 : 756 - 761
12345